Biom’up SA, specialising in surgical hemostasis, appointed Patrice Ferrand as their new CEO. Ferrand replaces Jan Ohrstrom, who was appointed CEO since May and remains Chairman of the Board.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2019-10-08 12:50:002019-10-08 12:50:00Patrice Ferrand named new Biom’up CEO
Many users in research labs like to store their assay components such as assay antibodies, conjugates, antigens, calibrators or coated ELISA plates for a while without losing functionality.
https://european-biotechnology.com/wp-content/uploads/2024/04/ClpP-ClpX-scaled.jpg17072560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-10-07 07:23:542019-10-07 07:23:54Researchers unravel how ADEP antibiotics work
A new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose.
https://european-biotechnology.com/wp-content/uploads/2024/04/HIV_Christian_Eggeling_Foto_Jan-Peter_Kasper_FSU_40d3247028.jpg600941Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-10-04 10:49:132019-10-04 10:49:13New method allows tracking of HIV
How can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels.
H.E.L. Group Ltd has a new CEO: The global manufacturer of laboratory tools for process optimisation, safety and scale-up announced the appointment of Louise Madden as Chief Executive Officer.
https://european-biotechnology.com/wp-content/uploads/2024/04/Asebio_Investor_Day_2019.jpg558992Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-10-01 08:15:002019-10-01 08:15:00Spanish sector attracting more and more investment
Patrice Ferrand named new Biom’up CEO
AppointmentsBiom’up SA, specialising in surgical hemostasis, appointed Patrice Ferrand as their new CEO. Ferrand replaces Jan Ohrstrom, who was appointed CEO since May and remains Chairman of the Board.
Qiagen/Illumina: Earthquake in NGS IVD market
Latest NewsQIAGEN and Illumina join forces in the next-gen sequencing-based IVD testing and companion diagnostics market announcing a 15-year collaboration.
Long-term stabilization of assay components
Sponsored PublicationsMany users in research labs like to store their assay components such as assay antibodies, conjugates, antigens, calibrators or coated ELISA plates for a while without losing functionality.
Researchers unravel how ADEP antibiotics work
Latest NewsGerman researchers have determined the mechanism of a ADEPs, a novel class of antibiotics, allowing for pharmacological optimisation.
New method allows tracking of HIV
Latest NewsA new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose.
Successful EFIB in Brussels
Latest NewsHow can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels.
Rottapharm Biotech: POC in osteoarthritis pain
Latest NewsRottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis.
H.E.L. Group: Realising market potential
AppointmentsH.E.L. Group Ltd has a new CEO: The global manufacturer of laboratory tools for process optimisation, safety and scale-up announced the appointment of Louise Madden as Chief Executive Officer.
Spanish sector attracting more and more investment
Latest NewsCreoptix AG closes CHF8m financing round
Latest NewsSwiss drug discovery analytics specialist Creoptix AG has raised CHF8m in a Series C financing for commercial expansion.